Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C55H69N13O12S2Tc.C6H11N2O4.C6H10N2O4 |
| Molecular Weight | 1616.57 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CNCCNCC([O-])=O.[O-]C(=O)CNCCNCC([O-])=O.C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)C3=CC=C(NN=[99Tc+3])N=C3)C(=O)N[C@@H](CC4=CC=C(O)C=C4)C(=O)N[C@H](CC5=CNC6=C5C=CC=C6)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1
InChI
InChIKey=BHDKCRZDRQYHDH-JMGZEQTNSA-K
InChI=1S/C55H69N13O12S2.2C6H12N2O4.Tc/c1-30(70)43(27-69)64-54(79)45-29-82-81-28-44(65-51(76)40(22-32-10-4-3-5-11-32)61-48(73)34-17-20-46(68-57)59-25-34)53(78)62-41(23-33-15-18-36(72)19-16-33)50(75)63-42(24-35-26-58-38-13-7-6-12-37(35)38)52(77)60-39(14-8-9-21-56)49(74)67-47(31(2)71)55(80)66-45;2*9-5(10)3-7-1-2-8-4-6(11)12;/h3-7,10-13,15-20,25-26,30-31,39-45,47,58,69-72H,8-9,14,21-24,27-29,56H2,1-2H3,(H,59,68)(H,60,77)(H,61,73)(H,62,78)(H,63,75)(H,64,79)(H,65,76)(H,66,80)(H,67,74);2*7-8H,1-4H2,(H,9,10)(H,11,12);/q;;;+3/p-3/t30-,31-,39+,40-,41+,42-,43-,44+,45+,47+;;;/m1.../s1/i;;;1+1
| Molecular Formula | C55H68N13O12S2Tc |
| Molecular Weight | 1266.245 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 3 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C6H12N2O4 |
| Molecular Weight | 176.1705 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 23:43:05 GMT 2025
by
admin
on
Tue Apr 01 23:43:05 GMT 2025
|
| Record UNII |
534I87AT7J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
661918
Created by
admin on Tue Apr 01 23:43:05 GMT 2025 , Edited by admin on Tue Apr 01 23:43:05 GMT 2025
|
||
|
WHO-ATC |
V09IA07
Created by
admin on Tue Apr 01 23:43:05 GMT 2025 , Edited by admin on Tue Apr 01 23:43:05 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000008344
Created by
admin on Tue Apr 01 23:43:05 GMT 2025 , Edited by admin on Tue Apr 01 23:43:05 GMT 2025
|
PRIMARY | |||
|
137331865
Created by
admin on Tue Apr 01 23:43:05 GMT 2025 , Edited by admin on Tue Apr 01 23:43:05 GMT 2025
|
PRIMARY | |||
|
534I87AT7J
Created by
admin on Tue Apr 01 23:43:05 GMT 2025 , Edited by admin on Tue Apr 01 23:43:05 GMT 2025
|
PRIMARY | |||
|
913556-61-3
Created by
admin on Tue Apr 01 23:43:05 GMT 2025 , Edited by admin on Tue Apr 01 23:43:05 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->RADIOLIGAND |
Binds with high affinity
|
||
|
TARGET->RADIOLIGAND |
Binds with high affinity
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|